ORAL PURGATIVE POWDER FOR SOLUTION

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Wirkstoff:

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Verfügbar ab:

ODAN LABORATORIES LTD

ATC-Code:

A06AB58

INN (Internationale Bezeichnung):

SODIUM PICOSULFATE, COMBINATIONS

Dosierung:

12G; 3.5G; 10MG

Darreichungsform:

POWDER FOR SOLUTION

Zusammensetzung:

CITRIC ACID 12G; MAGNESIUM OXIDE 3.5G; SODIUM PICOSULFATE 10MG

Verabreichungsweg:

ORAL

Einheiten im Paket:

100

Verschreibungstyp:

Ethical

Therapiebereich:

CATHARTICS AND LAXATIVES

Produktbesonderheiten:

Active ingredient group (AIG) number: 0350181002; AHFS:

Berechtigungsstatus:

CANCELLED POST MARKET

Berechtigungsdatum:

2017-06-22

Fachinformation

_ _
_ _
_Page 1 of 13_
PRESCRIBING INFORMATION
ORAL PURGATIVE
Magnesium oxide, citric acid and sodium picosulfate
Powder for oral solution
Purgative
Odan Laboratories Ltd.
Date of Revision:
325 Stillview Avenue
March 21, 2013
Pointe-Claire, Quebec
H9R 2Y6
CONTROL NO.: 162616
_ _
_ _
_Page 2 of 13_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................8
DOSAGE AND ADMINISTRATION
................................................................................8
OVERDOSAGE
..................................................................................................................9
STORAGE AND STABILITY
..........................................................................................10
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................10
PART II: CONSUMER INFORMATION
...............................................................................11
_ _
_ _
_Page 3 of 13_
ORAL PURGATIVE
Magnesium oxide, citric acid and sodium picosulfate
Powder for oral solution
Purgative
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM / STRENGTH
CLINICALLY RELEVANT NONMEDICINAL
INGREDIENTS
Oral
Each sachet contains:
Powder : citric acid 12g;
magnesium oxide 3.5 g;
sodium picosulfate 10 mg
For a complete li